Dojolvi Disease Interactions
There is 1 disease interaction with Dojolvi (triheptanoin).
Moderate
Triheptanoin (applies to Dojolvi) pancreatic insufficiency
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Pancreatitis, Diabetes Mellitus, Cystic Fibrosis
Avoid the administration of triheptanoin in patients with pancreatic insufficiency as reduced absorption will lead to insufficient supplementation.
References (1)
- (2020) "Product Information. Dojolvi (triheptanoin)." Ultragenyx Pharmaceutical
Switch to consumer interaction data
Dojolvi drug interactions
There is 1 drug interaction with Dojolvi (triheptanoin).
Report options
QR code containing a link to this page
More about Dojolvi (triheptanoin)
- Dojolvi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: oral nutritional supplements
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Featured
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Reviews & ratings
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
